Abstract:New Findings What is the central question of this study? In this study, we investigated whether MD1 interacted with the sympathetic nerves in ventricular arrhythmia (VA) during heart failure with preserved ejection fraction (HFpEF). What is the main finding and its importance? Mice with HFpEF showed increased susceptibility to VA, adverse electrical remodelling, impaired heart rate variability, enhanced sympathetic hyperactivity, activation of the NLRP3 inflammasome and increased interleukin‐1β release. These changes induced by HFpEF were exacerbated by MD1 deficiency. AbstractSympathetic hyperactivity can promote malignant ventricular arrhythmia (VA), and myeloid differentiation 1 (MD1) has been reported to play an important role in obesity‐induced VA. However, it is not known whether an interaction of MD1 with sympathetic hyperactivity contributes to the VA induced by heart failure with preserved ejection fraction (HFpEF). The aim of this study was to investigate the potential interaction between MD1 and sympathetic hyperactivity in HFpEF‐induced VA and the underlying mechanism. Eight‐week‐old MD1‐knockout (MD1‐KO) and wild‐type (WT) mice were subjected to a model of HFpEF induced by uninephrectomy, a continuous saline or d‐aldosterone infusion and provision of drinking water containing 1.0% sodium chloride for 4 weeks. Echocardiography and haemodynamics were used to verify the model of HFpEF. An isolated electrophysiological study was performed to assess the susceptibility to VA. Four weeks later, the mice with HFpEF showed an increased heart weight to tibia length ratio, decreased left ventricular minimum rates of pressure rise (dP/dtmin), increased τ, lung weight to tibia length ratio and preserved left ventricular ejection fraction compared with WT mice. The mice with HFpEF exhibited increased susceptibility to VA, as shown by the shortened effective refractory period, prolonged action potential duration (APD), increased APD alternans threshold and higher incidence of VA. Moreover, we also found that mice with HFpEF showed impaired heart rate variability, sympathetic hyperactivity, activation of the NLRP3 inflammasome and increased interleukin‐1β release. These changes induced by HFpEF were exacerbated by MD1 deficiency. We conclude that MD1‐KO contributes to sympathetic hyperactivity and facilitates VA in HFpEF via activation of the NLRP3 inflammasome. Treatment targeting MD1 and NLRP3 might decrease the risk of HFpEF‐induced VA.

Loss of MD1 Promotes Inflammatory and Apoptotic Atrial Remodelling in Diabetic Cardiomyopathy by Activating the TLR4/NF-κB Signalling Pathway

Overexpression of MD1 ameliorates pathological myocardial remodeling in diabetic cardiomyopathy by TLR4/STAT3 signaling pathway

MD1 Deficiency Promotes Inflammatory Atrial Remodelling Induced by High-Fat Diets

Loss of MD1 Exacerbates Pressure Overload-Induced Left Ventricular Structural and Electrical Remodelling

The Akt Pathway Mediates the Protective Effects of Myeloid Differentiation Protein 1 in Pathological Cardiac Remodelling

Myeloid differentiation protein 1 protected myocardial function against high-fat stimulation induced pathological remodelling.

Loss of MD1 Exacerbates Myocardial Ischemia/reperfusion Injury and Susceptibility to Ventricular Arrhythmia

Macrophage Migration Inhibitory Factor Deficiency Augments Cardiac Dysfunction in Type 1 Diabetic Murine Cardiomyocytes

ASSA13-06-6 Prevention of Cardiac Remodelling by Gene Silencing of Toll-Like Receptor-4 in Mice with Diabetic Cardiomyopathy

Loss of MD1 exacerbates myocardial ischemia/reperfusion injury and susceptibility to ventricular arrhythmia.

Loss of myeloid differentiation protein 1 promotes atrial fibrillationin heart failure with preserved ejection fraction.

Loss of MD1 Increases Vulnerability to Ventricular Arrhythmia in Diet-Induced Obesity Mice Via Enhanced Activation of the TLR4/MyD88/CaMKII Signaling Pathway.

Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling

MD1 Depletion Predisposes to Ventricular Arrhythmias in the Setting of Myocardial Infarction.

MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway.

Knockout of MD1 Contributes to Sympathetic Hyperactivity and Exacerbates Ventricular Arrhythmias Following Heart Failure with Preserved Ejection Fraction Via NLRP3 Inflammasome Activation

Mst1 Knockdown Alleviates Cardiac Lipotoxicity and Inhibits the Development of Diabetic Cardiomyopathy in Db/db Mice.

MD1 deletion exaggerates cardiomyocyte autophagy induced by heart failure with preserved ejection fraction through ROS/MAPK signalling pathway

miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1

MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway

Mst1 Knockout Alleviates Mitochondrial Fission and Mitigates Left Ventricular Remodeling in the Development of Diabetic Cardiomyopathy